BioPharma Dive 2026年5月11日 Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trial
BioPharma Dive 2026年5月11日 Precision in motion: Decoding the critical operations behind the logistics of next-generation cell and gene therapies
BioPharma Dive 2026年5月8日 FDA to reevaluate spurned cell therapy; Under-the-skin Leqembi review extended
BioPharma Dive 2026年5月7日 Roche to acquire digital pathology firm PathAI in deal potentially worth over $1B